These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 20005474)

  • 61. Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure.
    Hermann HP; Arp J; Pieske B; Kögler H; Baron S; Janssen PM; Hasenfuss G
    Eur J Heart Fail; 2004 Mar; 6(2):213-8. PubMed ID: 14984729
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ivabradine, a novel medication for treatment of heart failure with reduced ejection fraction.
    Foster JL; Bobadilla RV
    J Am Assoc Nurse Pract; 2016 Nov; 28(11):576-582. PubMed ID: 27215699
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis.
    Busseuil D; Shi Y; Mecteau M; Brand G; Gillis MA; Thorin E; Asselin C; Roméo P; Leung TK; Latour JG; Des Rosiers C; Bouly M; Rhéaume E; Tardif JC
    Cardiology; 2010; 117(3):234-42. PubMed ID: 21212673
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): A randomised study.
    Hidalgo FJ; Anguita M; Castillo JC; Rodríguez S; Pardo L; Durán E; Sánchez JJ; Ferreiro C; Pan M; Mesa D; Delgado M; Ruiz M
    Int J Cardiol; 2016 Aug; 217():7-11. PubMed ID: 27167103
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ivabradine: from molecular basis to clinical effectiveness.
    Riccioni G
    Adv Ther; 2010 Mar; 27(3):160-7. PubMed ID: 20419486
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction.
    Heusch G; Kleinbongard P
    Drugs; 2016 May; 76(7):733-40. PubMed ID: 27041289
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ivabradine for chronic heart failure?
    Drug Ther Bull; 2012 Oct; 50(10):117-20. PubMed ID: 23065752
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel drugs for heart rate control in heart failure.
    Bielecka-Dabrowa A; von Haehling S; Rysz J; Banach M
    Heart Fail Rev; 2018 Jul; 23(4):517-525. PubMed ID: 29594814
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure.
    Oliva F; Sormani P; Contri R; Campana C; Carubelli V; Cirò A; Morandi F; Di Tano G; Mortara A; Senni M; Metra M; Ammirati E
    Int J Cardiol; 2018 Feb; 253():97-104. PubMed ID: 29249470
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
    Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
    Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of ''off-label'' use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure.
    Sarullo FM; Fazio G; Puccio D; Fasullo S; Paterna S; Novo S; Di Pasquale P
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):349-55. PubMed ID: 20940450
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Use and Indication of Ivabradine in Heart Failure.
    Dodd K; Lampert BC
    Heart Fail Clin; 2018 Oct; 14(4):493-500. PubMed ID: 30266358
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease.
    Rimoldi SF; Messerli FH; Cerny D; Gloekler S; Traupe T; Laurent S; Seiler C
    Hypertension; 2016 Jun; 67(6):1205-10. PubMed ID: 27091900
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ivabradine for the treatment of chronic heart failure.
    Henri C; O'Meara E; De Denus S; Elzir L; Tardif JC
    Expert Rev Cardiovasc Ther; 2016; 14(5):553-61. PubMed ID: 26967048
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Heart rate and its reduction in chronic heart failure and beyond.
    Nikolovska Vukadinović A; Vukadinović D; Borer J; Cowie M; Komajda M; Lainscak M; Swedberg K; Böhm M
    Eur J Heart Fail; 2017 Oct; 19(10):1230-1241. PubMed ID: 28627045
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Chronic Heart Failure With Preserved Ejection Fraction: Effective Treatment Possible?].
    Kanorskiy SG; Borisenko YV
    Kardiologiia; 2018 Jun; 58(6):85-89. PubMed ID: 30362441
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ivabradine: A Current Overview.
    Guha K; Allen CJ; Hartley A; Sharma R
    Curr Clin Pharmacol; 2016; 11(4):241-249. PubMed ID: 27784216
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-ischaemic effect of ivabradine.
    Ferrari R; Cargnoni A; Ceconi C
    Pharmacol Res; 2006 May; 53(5):435-9. PubMed ID: 16644235
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of the effects of ivabradine and atenolol on heart rate and echocardiographic variables of left heart function in healthy cats.
    Riesen SC; Schober KE; Cervenec RM; Bonagura JD
    J Vet Intern Med; 2011; 25(3):469-76. PubMed ID: 21418320
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacological heart rate lowering in patients with a preserved ejection fraction-review of a failing concept.
    Meyer M; Rambod M; LeWinter M
    Heart Fail Rev; 2018 Jul; 23(4):499-506. PubMed ID: 29098508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.